Keyphrases
Cancer Cells
100%
PARP Inhibitor (PARPi)
100%
Drug Combination
100%
PARP-1 Inhibitor
100%
Overcoming Resistance
100%
Vorinostat
66%
6-Thioguanine (6-TG)
33%
Innate Resistance
33%
ABT-888
33%
Phosphorylation
22%
Cancer Cell Lines
22%
Cancer Treatment
22%
Acquired Resistance
22%
EIF2
22%
Sensitizing Effect
22%
Homologous Recombination Repair
22%
Downstream Effectors
11%
Multidrug-resistant
11%
BRCA mutation
11%
Liver Function
11%
Cellular Response
11%
Histone Deacetylase Inhibitor (HDACi)
11%
Skin Fibroblasts
11%
Kidney Function
11%
New Therapeutic Strategies
11%
Breast Cells
11%
Xenograft Tumor Growth
11%
Normal Breast
11%
Resistant Protein
11%
Medicine and Dentistry
Cancer Cell
100%
Combination Drug
100%
Vorinostat
100%
Poly ADP Ribose Polymerase
100%
Tioguanine
50%
Cancer Treatment
33%
Cancer Cell Line
33%
Recombination Repair
33%
Initiation Factor 2
33%
Homologous Recombination
33%
Tumor Progression
16%
Cancer
16%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
16%
Kidney Function
16%
Xenograft
16%
Liver Function
16%
BRCA Mutation
16%
Histone Deacetylase Inhibitor
16%
Breast Cell
16%
Fibroblast
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Combination Drug
100%
Vorinostat
100%
Tioguanine
50%
Initiation Factor 2
33%
Tumor Growth
16%
Histone Deacetylase Inhibitor
16%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
16%